2.285

0.00% 0.005

Nuvation Bio Inc (NUVB)

Overview News Price History Option Chain Discussions Forecast

Nuvation Bio Inc stock is traded at $2.285, with a volume of 667.72K. It is up +0.00% in the last 24 hours and down -4.98% over the past month. Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Previous Close:

$2.29

Open:

$2.27

24h Volume:

667.72K

Relative Volume:

0.45

Market Cap:

$764.97M

Revenue:

Net Income/Loss:

$-75.80M

P/E Ratio:

-5.5732

EPS:

-0.41

Net Cash Flow:

$-68.07M

1W Performance:

-2.97%

1M Performance:

-4.98%

6M Performance:

-28.88%

1Y Performance:

+69.63%

1-Day Range:

$2.18

$2.305

1-Week Range:

$2.18

$2.515

52-Week Range:

$1.21

$4.1598

Nuvation Bio Inc Stock (NUVB) Company Profile

Name

Nuvation Bio Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

(415) 754-3517

Address

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Employee

167

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

NUVB's Discussions on Twitter

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-23	Downgrade	Jefferies	Buy → Hold
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
May-04-22	Initiated	H.C. Wainwright	Buy
Oct-15-21	Resumed	BTIG Research	Buy
Apr-06-21	Initiated	RBC Capital Mkts	Outperform
Mar-08-21	Initiated	BMO Capital Markets	Outperform
Mar-08-21	Initiated	BTIG Research	Buy
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	Jefferies	Buy
Mar-08-21	Initiated	Wedbush	Outperform

View All

Nuvation Bio Inc Stock (NUVB) Latest News

Oct 30, 2024

Nuvation Bio (NYSE:NUVB) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Oct 30, 2024

Oct 26, 2024

Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market (NYSE:NUVB) - Seeking Alpha

Oct 21, 2024

Oct 20, 2024

Financial Survey: Neoleukin Therapeutics (NASDAQ:NLTX) & Nuvation Bio (NYSE:NUVB) - Defense World

Oct 20, 2024

Oct 17, 2024

Nuvation Bio (NYSE:NUVB) Stock Price Down 5.8%Time to Sell? - MarketBeat

Oct 17, 2024

This Biotech Stock Insider is Buying Shares, Should You? - Inkl

Oct 17, 2024

This Biotech Stock Insider Is Buying Shares, Should You? - Barchart

Oct 17, 2024

Oct 16, 2024

Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? - Insider Monkey

Oct 16, 2024

Robert Mashal Spends US$220k On Nuvation Bio Shares - Simply Wall St

Oct 16, 2024

Robert Mashal At Nuvation Bio Tops Up Holding By US$220k - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Is Nuvation Bio Inc (NUVB) a opportunity to investors? - US Post News

Oct 15, 2024

Oct 14, 2024

The Attractiveness of Investing In Nuvation Bio Inc (NUVB) is Growing - Knox Daily

Oct 14, 2024

Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock? - Insider Monkey

Oct 14, 2024

Trading Day Review: Nuvation Bio Inc (NUVB) Gains Momentum, Closing at 2.27 - The Dwinnex

Oct 14, 2024

The Significance of Moving Averages in Nuvation Bio Inc Inc. (NUVB) Price Performance - The InvestChronicle

Oct 14, 2024

Oct 11, 2024

Nuvation Bio (NYSE:NUVB) Trading Up 10.4% Following Insider Buying Activity - MarketBeat

Oct 11, 2024

Nuvation Bio director acquires $220k in company stock By Investing.com - Investing.com South Africa

Oct 11, 2024

Dimensional Fund Advisors LP Boosts Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat

Oct 11, 2024

Oct 10, 2024

Insider Buying: Nuvation Bio Inc. (NYSE:NUVB) Director Acquires 100,000 Shares of Stock - MarketBeat

Oct 10, 2024

Nuvation Bio director acquires $220k in company stock - Investing.com

Oct 10, 2024

Director Cui Xiangmin acquire 277,895 shares of Nuvation Bio Inc [NUVB] - Knox Daily

Oct 10, 2024

Views of Wall Street’s Leading Experts on Nuvation Bio Inc - SETE News

Oct 10, 2024

Nuvation Bio (NYSE:NUVB) Stock Price Down 5.4%Here's What Happened - MarketBeat

Oct 10, 2024

Oct 09, 2024

Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 - Insider Monkey

Oct 09, 2024

Oct 08, 2024

Nuvation Bio (NYSE:NUVB) Shares Gap UpTime to Buy? - MarketBeat

Oct 08, 2024

The NUVB Stock Puzzle: Unraveling Nuvation Bio Inc’s Fluctuating Performance - The InvestChronicle

Oct 08, 2024

Should Nuvation Bio Inc (NYSE: NUVB) Investors Be Concerned? - Stocks Register

Oct 08, 2024

Nuvation Bio appoints new CFO ahead of commercial phase - Investing.com

Oct 08, 2024

Oct 07, 2024

Nuvation Bio Announces Philippe Sauvage as New CFO - TipRanks

Oct 07, 2024

Nuvation Bio Names Philippe Sauvage Chief Financial Officer - MarketWatch

Oct 07, 2024

Nuvation Bio appoints new CFO ahead of commercial phase By Investing.com - Investing.com UK

Oct 07, 2024

Nuvation Bio names Philippe Sauvage CFO - TipRanks

Oct 07, 2024

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer - Business Wire

Oct 07, 2024